A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer - Concepedia

Concepedia

Publication | Open Access

A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer

DOI Full Paper Access

122

Citations

25

References

2019

Year

Richard Tuli, Stephen L. Shiao, Nicholas N. Nissen, Mourad Tighiouart, Sungjin Kim, Arsen Osipov, Miranda Bryant, Lindsey Ristow, Veronica Placencio-Hickok, David Hoffman,

References

	Year	Citations

Page 1